Stock listing
Munich:6MD Medacta Group SA Aktie
German listing (Munich) of Medacta Group SA · home listing SIX Swiss:MOVE
Follow Medacta Group SA into a list and get an email when it puts out news.
Home listing price · SIX:MOVE
101.20 CHF -3.60 (-3.4%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, SIX:MOVE
- Day range
- 100.60 – 103.20 CHFNov 20, 2026
- Volume
- 24,702 sharesNov 20, 2026
- Market cap
- 2.02B CHFAt the close on Nov 20, 2026 · price × 19.95M shares outstanding
- 52-week range
- 100.60 – 177.20 CHFLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- 3.84M CHFMedian day 28,890 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| SIX Swiss:MOVE · Home | 101.20 CHF | -3.60 (-3.4%) | 24,702 | 102.60 | 103.20 | 100.60 | 104.80 | Close on Nov 20, 2026 |
| LSE:0A05 | 101.40 CHF | -1.80 (-1.7%) | 2,897 | 102.80 | 102.80 | 101.00 | 103.20 | Close on Nov 20, 2026 |
| Frankfurt:6MD | €109.00 EUR | -1.00 (-0.9%) | — | €110.00 | €110.00 | €109.00 | €110.00 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · SIX:MOVE · CHF, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 101.20 | -3.60 | -3.4% | 102.60 | 103.20 | 100.60 | 24,702 | |
| 104.80 | -0.20 | -0.2% | 105.00 | 106.40 | 104.80 | 24,889 | |
| 105.00 | -2.20 | -2.1% | 107.20 | 107.20 | 104.20 | 30,971 | |
| 107.20 | -0.80 | -0.7% | 109.40 | 109.40 | 107.00 | 29,996 | |
| 108.00 | -0.60 | -0.6% | 108.80 | 109.00 | 107.00 | 57,566 | |
| 108.60 | -1.40 | -1.3% | 110.40 | 111.60 | 107.80 | 59,869 | |
| 110.00 | +0.40 | +0.4% | 110.00 | 111.80 | 109.60 | 28,984 | |
| 109.60 | +1.40 | +1.3% | 109.40 | 111.60 | 109.00 | 40,473 | |
| 108.20 | +1.80 | +1.7% | 108.00 | 110.40 | 106.60 | 73,194 | |
| 106.40 | -16.80 | -13.6% | 113.00 | 113.00 | 104.80 | 142,075 | |
| 123.20 | -0.80 | -0.6% | 124.20 | 126.00 | 123.20 | 16,411 | |
| 124.00 | +5.60 | +4.7% | 117.80 | 124.80 | 117.60 | 29,434 | |
| 118.40 | +0.20 | +0.2% | 117.80 | 119.00 | 117.20 | 15,449 | |
| 118.20 | +0.60 | +0.5% | 117.00 | 119.20 | 115.40 | 19,975 | |
| 117.60 | -3.40 | -2.8% | 121.60 | 121.60 | 117.60 | 77,055 | |
| 121.00 | +1.40 | +1.2% | 119.80 | 121.60 | 119.00 | 29,374 | |
| 119.60 | +0.80 | +0.7% | 118.20 | 121.60 | 118.20 | 19,704 | |
| 118.80 | -1.20 | -1.0% | 120.00 | 120.20 | 118.40 | 23,435 | |
| 120.00 | +1.40 | +1.2% | 119.80 | 121.40 | 118.60 | 28,796 | |
| 118.60 | -0.60 | -0.5% | 119.20 | 119.40 | 117.40 | 29,324 | |
| 119.20 | +3.00 | +2.6% | 116.60 | 119.40 | 116.60 | 27,027 | |
| 116.20 | 0.00 | 0.0% | 116.60 | 117.60 | 115.60 | 16,034 | |
| 116.20 | +1.20 | +1.0% | 115.00 | 116.40 | 114.40 | 14,094 | |
| 115.00 | -1.00 | -0.9% | 115.00 | 115.60 | 113.80 | 19,896 | |
| 116.00 | +0.60 | +0.5% | 116.00 | 118.40 | 115.40 | 18,459 | |
| 115.40 | +1.00 | +0.9% | 114.60 | 116.00 | 113.00 | 20,502 | |
| 114.40 | +0.40 | +0.4% | 114.00 | 116.20 | 114.00 | 29,231 | |
| 114.00 | -0.20 | -0.2% | 114.00 | 115.60 | 113.40 | 20,660 | |
| 114.20 | 0.00 | 0.0% | 114.20 | 115.40 | 113.40 | 22,079 | |
| 114.20 | +2.80 | +2.5% | 112.00 | 115.20 | 112.00 | 32,045 | |
| 111.40 | -2.80 | -2.5% | 113.00 | 113.00 | 111.20 | 36,613 | |
| 114.20 | -0.40 | -0.3% | 113.60 | 116.20 | 113.60 | 26,404 | |
| 114.60 | 0.00 | 0.0% | 115.00 | 116.60 | 114.40 | 18,279 | |
| 114.60 | +1.20 | +1.1% | 113.60 | 115.60 | 113.00 | 25,207 | |
| 113.40 | -0.20 | -0.2% | 112.60 | 114.40 | 112.40 | 22,023 | |
| 113.60 | -0.60 | -0.5% | 113.00 | 115.40 | 112.60 | 24,275 | |
| 114.20 | -1.20 | -1.0% | 115.40 | 117.20 | 113.60 | 61,239 | |
| 115.40 | +0.40 | +0.3% | 115.00 | 117.20 | 114.60 | 30,345 | |
| 115.00 | +1.00 | +0.9% | 116.00 | 118.00 | 115.00 | 37,111 | |
| 114.00 | +1.40 | +1.2% | 113.00 | 114.60 | 111.60 | 27,546 | |
| 112.60 | -1.40 | -1.2% | 115.00 | 115.00 | 112.60 | 31,190 | |
| 114.00 | 0.00 | 0.0% | 113.60 | 115.60 | 113.40 | 45,529 | |
| 114.00 | +2.40 | +2.2% | 112.00 | 115.00 | 111.60 | 31,992 | |
| 111.60 | +2.60 | +2.4% | 109.40 | 113.40 | 109.00 | 49,491 | |
| 109.00 | -1.00 | -0.9% | 109.00 | 111.00 | 107.80 | 55,078 | |
| 110.00 | -0.80 | -0.7% | 110.00 | 111.00 | 108.60 | 41,300 | |
| 110.80 | +0.20 | +0.2% | 109.80 | 110.80 | 107.40 | 54,933 | |
| 110.60 | -4.80 | -4.2% | 114.20 | 114.20 | 110.00 | 50,666 | |
| 115.40 | +1.80 | +1.6% | 115.00 | 117.20 | 115.00 | 38,284 | |
| 113.60 | -3.20 | -2.7% | 116.80 | 117.60 | 113.60 | 37,906 | |
| 116.80 | -1.20 | -1.0% | 118.60 | 118.80 | 115.80 | 45,047 | |
| 118.00 | -4.60 | -3.8% | 120.40 | 124.60 | 116.40 | 56,868 | |
| 122.60 | -3.00 | -2.4% | 125.40 | 126.40 | 122.60 | 23,195 | |
| 125.60 | -0.40 | -0.3% | 125.20 | 126.20 | 123.40 | 11,140 | |
| 126.00 | +0.40 | +0.3% | 133.00 | 133.00 | 125.40 | 18,029 | |
| 125.60 | -1.80 | -1.4% | 128.40 | 128.60 | 123.60 | 45,954 | |
| 127.40 | +2.80 | +2.2% | 124.20 | 127.80 | 123.80 | 23,406 | |
| 124.60 | -1.60 | -1.3% | 126.40 | 127.40 | 123.80 | 40,089 | |
| 126.20 | -0.20 | -0.2% | 126.40 | 127.20 | 125.60 | 28,254 | |
| 126.40 | -0.80 | -0.6% | 126.80 | 127.20 | 125.40 | 17,662 | |
| 127.20 | -0.20 | -0.2% | 127.20 | 128.20 | 126.00 | 29,770 | |
| 127.40 | 0.00 | 0.0% | 128.20 | 128.60 | 126.80 | 17,559 | |
| 127.40 | -1.40 | -1.1% | 129.20 | 129.20 | 127.40 | 20,554 | |
| 128.80 | -0.20 | -0.2% | 129.60 | 130.20 | 128.20 | 18,746 | |
| 129.00 | +0.40 | +0.3% | 128.40 | 129.00 | 127.40 | 15,478 | |
| 128.60 | -1.40 | -1.1% | 131.00 | 131.20 | 128.60 | 28,777 |
- Ticker
- Munich:6MD
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- Munich
- Currency
- EUR
What changed lately
Latest news release · Sep 9, 2026
Medacta Group SA: Medacta Group SA reports above-market revenue growth of 9.7% in constant currency1 with a robust adjusted EBITDA margin of 27.8% in c.c.1 in H1 2026
Latest earnings call · Sep 9, 2026
Medacta Group (SIX Swiss: MOVE) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Sep 9, 2026
H1 2026 Earnings Presentation
Earnings · 24 slides
Latest news
Medacta Group SA: Medacta Group SA reports above-market revenue growth of 9.7% in constant currency1 with a robust adjusted EBITDA margin of 27.8% in c.c.1 in H1 2026
Sep 9, 2026
Closed 118.00 (-3.8%) on Sep 9, 2026
Medacta Group SA: Medacta reports continued above-market revenue growth of 9.7% in c.c. in H1 2026
Jul 31, 2026
Closed 132.00 (-2.5%) on Jul 31, 2026
Media Release: Medacta announces the results of today's Annual General Meeting
May 6, 2026
Closed 143.60 (+2.0%) on May 6, 2026
Medacta announces the results of today's Annual General Meeting
May 5, 2026
Closed 143.60 (+2.0%) on May 6, 2026
Medacta Extends MyImplant Platform to Complex Hip Reconstruction
Apr 2, 2026
Closed 153.80 (-0.3%) on Apr 2, 2026
Medacta Group SA: Medacta Group reports record results in Full Year 2025 and upgrades mid-term guidance
Mar 13, 2026
Closed 155.80 (+1.8%) on Mar 13, 2026
Medacta Group SA: Medacta Group reports continued significant above-market revenue growth of 18.5% in constant currency in 2025
Feb 3, 2026
Closed 158.00 (-5.5%) on Feb 3, 2026
Medacta Launches GMK SpheriKA in Japan: Redefining Patient Satisfaction in Total Knee Replacement at JKS
Dec 18, 2025
Closed 152.00 (+0.7%) on Dec 18, 2025
Medacta Group SA on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 8 in the last 12 months · 18 in all · newest Sep 9, 2026 · oldest 2025
- Calls
- 6 calls with a replay · 6 with a transcript · latest Sep 9, 2026
- Decks
- 20 decks · latest Sep 9, 2026
Where Medacta Group SA is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| SIX Swiss:MOVE · Home listing | SIX Swiss | Switzerland | CHF |
| LSE:0A05 | LSE | United Kingdom | CHF |
| LS Exchange:A2PFTD | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2PFTD | Lang & Schwarz | Germany | EUR |
| Turquoise:MOVEZ | Turquoise | United Kingdom | CHF |
| Aquis:MOVEZ | Aquis | United Kingdom | CHF |
| gettex:6MD | gettex | Germany | EUR |
| BX Swiss:6MD | BX Swiss | Switzerland | CHF |
| Dusseldorf:6MD | Dusseldorf | Germany | EUR |
| Frankfurt:6MD | Frankfurt | Germany | EUR |
| Munich:6MD · This page | Munich | Germany | EUR |
| OTC:MEDGF | OTC | United States | USD |
| Stuttgart:6MD | Stuttgart | Germany | EUR |
Valuation
P/E 22.8× against a median of 26.8×: 2nd lowest of 8 Medical devices & supplies companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- 2.28B CHF
- P/E
- 22.8×
- EV/sales
- 3.6×
- EV/EBITDA
- 13.0×
- Price/book
- 4.5×
- Gross margin
- 64.1%
- Operating margin
- 16.8%
- Net margin
- 14.0%
- Debt to equity
- 0.7×
- Beta
- No index for this market yet
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Medacta Group SA · SIX:MOVE | US$2.40B | US$2.72B | 22.8× | 3.6× | 13.0× | 4.5× | 14.0% | 0.7× | n/a |
| Shanghai MicroPort MedBot (Group) Co., Ltd. Class H · HKEX:2252 | US$2.77B | US$2.74B | n/a | 33.1× | n/a | 44.9× | −45.3% | 1.0× | n/a |
| Ottobock SE & Co. KGaA · XETR:OBCK | US$2.65B | US$3.54B | 26.8× | 1.9× | 8.0× | 6.1× | 5.4% | 2.3× | n/a |
| Winner Medical Co. Ltd. Class A · SZSE:300888 | US$2.47B | US$1.75B | 21.2× | 1.0× | n/a | 1.4× | 6.9% | 0.0× | n/a |
| Double Medical Technology, Inc. Class A · SZSE:002901 | US$2.34B | US$2.16B | 24.1× | 5.1× | n/a | 4.4× | 23.1% | 0.1× | n/a |
| Micro-Tech (Nanjing) Co., Ltd. Class A · SSE:688029 | US$2.27B | US$2.00B | 31.7× | 4.0× | n/a | 3.6× | 14.3% | 0.0× | n/a |
| UFP Technologies, Inc. · NASDAQ:UFPT | US$2.25B | US$2.33B | 29.4× | 3.6× | 19.8× | 4.6× | 11.8% | 0.2× | 1.47 |
| Jafron Biomedical Co., Ltd. Class A · SZSE:300529 | US$2.24B | US$1.84B | 22.8× | 5.9× | n/a | 4.1× | 31.7% | 0.1× | n/a |
| Elekta AB Class B · OMXSTO:EKTA_B | US$2.18B | US$2.62B | n/a | 1.6× | 15.2× | 2.9× | −2.2% | 0.9× | n/a |
| Bonesupport Holding AB · OMXSTO:BONEX | US$2.07B | US$2.02B | 77.8× | 14.7× | 56.0× | 21.3× | 19.4% | 0.0× | n/a |
| Establishment Labs Holdings Inc. · NASDAQ:ESTA | US$2.06B | US$2.25B | n/a | 8.5× | n/a | 132× | −14.6% | 17.2× | 1.29 |
| Median of the others | US$2.26B | US$2.20B | 26.8× | 4.6× | 17.4× | 4.5× | 9.3% | 0.1× | 1.38 |
Forecasts
Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.
- Price target
- 149.63 CHF · Analysts' mean
- EPS, year to Dec 2026
- 4.67 · 5 analysts
- Revenue, year to Dec 2026
- 758.1M · 6 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Francesco Siccardi | CEO |
| Corrado Farsetta | CFO |
| Anja Pomrehn | Group VP Sustainability and Investor & Media Relations |
| Alessandro Siccardi | CSCO (Chief Supply Chain Officer) |
| Asif Hussain | Chief People Officer |
| Giovanni Niccolò Galli | CCO (Chief Commercial Officer) |
| Massimiliano Bernardoni | Chief Innovation Officer |
Board
| Director | Role |
|---|---|
| Alberto Siccardi | Chairman |
| Maria Luisa Siccardi Tonolli | Member |
| Philippe Weber | Member, Independent Director |
| Riccardo Braglia | Member, Independent Director |
| Victor Balli | Member, Lead Independent Director |
Events
- Next results
- Mar 10, 2027 (expected)
Calls
| Call | When | Status |
|---|---|---|
| Medacta Group (SIX Swiss: MOVE) Q2 2026 Earnings Call | Wed, Sep 09, 2026 · 10:00 AM ET | Replay |
| Medacta Group (SIX Swiss: MOVE) Q4 2025 Earnings Call | Fri, Mar 13, 2026 · 10:00 AM ET | Replay |
| Medacta Group (SIX Swiss: MOVE) Q1 2025 Earnings Call | Mon, Sep 08, 2025 · 8:00 AM ET | Replay |
| Medacta Group (SIX Swiss: MOVE) Q4 2024 Earnings Call | Tue, Mar 25, 2025 · 8:00 AM ET | Replay |
| Medacta Group (SIX Swiss: MOVE) Q2 2024 Earnings Call | Thu, Jul 25, 2024 · 8:00 AM ET | Replay |
| Medacta Group (SIX Swiss: MOVE) Q1 2020 Earnings Call | Thu, May 14, 2020 | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q4 2025 | Dec 31, 2025 | +1.3% |
| Q2 2025 | Sep 8, 2025 · After close | +1.2% |
| Q4 2024 | Mar 25, 2025 | +3.8% |
| Q4 2022 | Mar 17, 2023 · Before open | +0.4% |
| Q2 2022 | Sep 9, 2022 · After close | −0.3% |
| Q4 2021 | Mar 11, 2022 · Before open | −4.7% |
| Q2 2021 | Sep 10, 2021 | +6.1% |
| Q4 2020 | Mar 31, 2021 | −4.0% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| H1 2026 Earnings Presentation | Earnings | 24 slides | Sep 9, 2026 |
| FY2025 Earnings Presentation | Earnings | 25 slides | Mar 13, 2026 |
| H1 2025 Earnings Presentation | Earnings | 24 slides | Sep 8, 2025 |
| FY2024 Earnings Presentation | Earnings | 27 slides | Mar 25, 2025 |
| H1 2024 Earnings Presentation | Earnings | 14 slides | Jul 25, 2024 |
| FY2022 Earnings Presentation | Earnings | 17 slides | Mar 17, 2023 |
| H1 2022 Earnings Presentation | Earnings | 17 slides | Sep 9, 2022 |
| H1 2022 Earnings Presentation | Earnings | 11 slides | Jul 29, 2022 |
| FY2021 Earnings Presentation | Earnings | 20 slides | Mar 11, 2022 |
| FY2021 Earnings Presentation | Earnings | 14 slides | Jan 20, 2022 |
All 20 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| H1 2021 Earnings Presentation | Earnings | 21 slides | Sep 10, 2021 |
| H1 2021 Earnings Presentation | Earnings | 10 slides | Jul 20, 2021 |
| FY2020 Earnings Presentation | Earnings | 23 slides | Mar 31, 2021 |
| FY2020 Earnings Presentation | Earnings | 11 slides | Jan 21, 2021 |
| H1 2020 Earnings Presentation | Earnings | 21 slides | Sep 7, 2020 |
| H1 2020 Earnings Presentation | Earnings | 13 slides | Jul 22, 2020 |
| FY2019 Earnings Presentation | Earnings | 39 slides | Apr 6, 2020 |
| FY2019 Earnings Presentation | Earnings | 10 slides | Jan 21, 2020 |
| J.P. Morgan 38th Annual Healthcare Conference (January 2020) | Conference | 18 slides | January 2020 |
| H1 2019 Earnings Presentation | Earnings | 25 slides | Sep 3, 2019 |
Financials
Annual, in EUR
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 688.3M | 590.6M | 510.8M | 437.1M | 363.1M | 302.5M | 310.6M | 272.6M | 244.7M | 219.1M |
| Cost of revenue | 246.9M | 191.1M | 162.9M | 131.9M | 101.9M | 88.2M | 86.9M | 68.6M | 62.1M | 54.5M |
| Gross profit | 441.4M | 399.4M | 347.8M | 305.3M | 261.2M | 214.3M | 223.7M | 204.0M | 182.6M | 164.6M |
| Research and development | 13.0M | 21.4M | 20.3M | 16.2M | 11.3M | 6.83M | 7.64M | 3.93M | 3.48M | 3.11M |
| Selling, general and administrative | 26.4M | 21.3M | 65.8M | 60.6M | 49.8M | 45.2M | 49.3M | 9.67M | 9.44M | 10.5M |
| Operating income | 115.7M | 90.8M | 74.4M | 61.5M | 58.8M | 49.4M | 40.1M | 61.5M | 49.7M | 49.5M |
| Depreciation and amortization | 74.4M | 65.2M | 57.7M | 51.0M | 40.0M | 37.0M | 33.7M | 24.8M | 22.4M | 18.7M |
| EBITDA | 190.1M | 156.1M | 132.1M | 112.5M | 98.8M | 86.5M | 73.8M | 86.3M | 72.0M | 68.2M |
| Interest expense | 6.85M | 7.51M | 6.83M | 3.66M | 3.44M | 3.04M | 3.36M | 2.10M | 1.69M | 1.19M |
| Income before tax | 116.0M | 87.8M | 58.7M | 54.8M | 55.5M | 39.9M | 13.6M | 58.0M | 47.4M | 48.6M |
| Income tax | 20.0M | 14.9M | 11.4M | 8.54M | 3.93M | 2.84M | 1.77M | 12.3M | 13.9M | 9.40M |
| Net income | 96.1M | 72.9M | 47.4M | 46.2M | 51.5M | 37.1M | 11.9M | 45.8M | 33.5M | 39.2M |
| Earnings per share, basic | 4.81 | 3.65 | 2.37 | 2.31 | 2.58 | 1.85 | 0.59 | 2.29 | 1.67 | 1.96 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 33.2M | 31.6M | 20.8M | 32.3M | 20.4M | 48.1M | 27.2M | 33.7M | 25.1M | 20.7M |
| Short-term investments | 3.91M | 4.69M | 7.05M | 802.0K | 0 | 1.30M | 259.0K | 240.0K | 0 | 500.0K |
| Receivables | 132.5M | 108.5M | 94.7M | 78.0M | 59.4M | 45.8M | 48.0M | 48.2M | 36.9M | 36.1M |
| Inventory | 275.9M | 234.4M | 213.9M | 160.3M | 136.1M | 114.2M | 101.6M | 89.2M | 72.5M | 67.4M |
| Current assets | 449.7M | 395.4M | 348.5M | 283.7M | 228.0M | 217.7M | 187.8M | 174.6M | 139.3M | 129.0M |
| Property, plant and equipment | 386.0M | 317.5M | 267.3M | 218.5M | 179.7M | 153.4M | 157.5M | 132.9M | 101.5M | 100.9M |
| Goodwill | 59.0K | 59.0K | 59.0K | 59.0K | 59.0K | 59.0K | 59.0K | 59.0K | 59.0K | 0 |
| Total assets | 916.9M | 792.2M | 695.9M | 584.5M | 489.3M | 441.9M | 412.6M | 365.6M | 299.8M | 269.7M |
| Accounts payable | 49.8M | 35.4M | 38.9M | 28.5M | 26.0M | 16.5M | 17.8M | 20.1M | 17.3M | 11.2M |
| Current liabilities | 216.5M | 157.5M | 149.4M | 89.1M | 136.6M | 144.8M | 120.5M | 114.1M | 92.1M | 60.3M |
| Long-term debt | 113.5M | 142.9M | 114.8M | 135.9M | 47.7M | 65.0M | 85.0M | 106.9M | 50.3M | 12.9M |
| Total debt | 262.6M | 241.2M | 202.0M | 170.2M | 132.7M | 150.0M | 152.2M | 162.9M | 97.6M | 41.2M |
| Total liabilities | 460.7M | 412.5M | 365.8M | 309.8M | 262.9M | 277.2M | 289.3M | 276.5M | 198.1M | 122.8M |
| Shareholders' equity | 456.2M | 379.7M | 330.0M | 274.7M | 226.4M | 164.7M | 123.2M | 89.1M | 101.7M | 146.9M |
| Shares outstanding | 20.0M | 19.9M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 153.7M | 107.1M | 75.1M | 73.5M | 54.1M | 59.6M | 42.6M | 66.4M | 51.6M | 56.3M |
| Capital spending | -123.8M | -104.7M | -82.2M | -63.2M | -46.5M | -27.3M | -41.5M | -55.1M | -40.1M | -28.3M |
| Free cash flow | 29.9M | 2.45M | -7.09M | 10.4M | 7.57M | 32.3M | 1.16M | 11.3M | 11.5M | 28.0M |
| Cash from investing | -137.9M | -98.9M | -80.6M | -65.1M | -52.0M | -34.2M | -42.0M | -49.2M | -44.9M | -33.8M |
| Cash from financing | -18.9M | 4.33M | -10.1M | 3.44M | -31.2M | -6.03M | -11.0M | -9.52M | -1.03M | -9.10M |
| Dividends paid | -14.8M | -11.2M | -11.1M | -10.4M | -10.4M | -10.4M | -10.4M | -65.2M | -62.8M | -62.8M |
| Share buybacks | -6.22M | -4.79M | -3.91M | -2.92M | -1.24M | 0 | 21.2M | |||
| Change in cash | 1.35M | 10.8M | -11.5M | 11.9M | -27.7M | 20.8M | -6.47M | 8.59M | 4.41M | 13.4M |
Cap table
Built by 6ix from Medacta Group SA’s releases
- Common shares
- 19,946,244
- Fully diluted
- 19,946,244
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 19,946,244 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 19,946,244 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Alberto Siccardi | Chairman · Since at least May 6, 2026 |
| Alessandro Siccardi | CSCO (Chief Supply Chain Officer) · Since at least Nov 5, 2026 |
| Anja Pomrehn | Group VP Sustainability and Investor & Media Relations · Since at least Sep 9, 2026 |
| Asif Hussain | Chief People Officer · Since at least Nov 5, 2026 |
| Corrado Farsetta | CFO · Since at least Sep 9, 2026 |
| Francesco Siccardi | CEO · Since at least Sep 9, 2026 |
| Giovanni Niccolò Galli | CCO (Chief Commercial Officer) · Since at least Nov 5, 2026 |
| Maria Luisa Siccardi Tonolli | Member · Since at least May 6, 2026 |
| Massimiliano Bernardoni | Chief Innovation Officer · Since at least Nov 5, 2026 |
| Philippe Weber | Member, Independent Director · Since at least May 6, 2026 |
All 12 people
| Person | Seat |
|---|---|
| Riccardo Braglia | Member, Independent Director · Since at least May 6, 2026 |
| Victor Balli | Member, Lead Independent Director · Since at least May 6, 2026 |
Log in to ask 6ix AI your own questions about Medacta Group SA.